Our Insights

Rethinking Evidence Planning in JCA Era

The first Joint Clinical Assessment reports reveal new expectations for pharmaceutical evidence planning. Explore the implications for trial design, PICO anticipation, cross-functional governance, and AI-enabled HTA readiness.

Read more →

The Wall at the Trading Desk

Agentic AI can already support research, recommendations, and risk checks in capital markets. The harder challenge begins at execution, where firms need clear accountability, supervision, information controls, and governance architecture before agents can move closer to autonomous decisions.

Read more →

What's trending

Other Insights

The Wall at the Trading Desk

Agentic AI can already support research, recommendations, and risk checks in capital markets. The harder challenge begins at execution, where firms need clear accountability, supervision, information controls, and governance architecture before agents can move closer to autonomous decisions.

Leia +

The Wall at the Trading Desk

Agentic AI can already support research, recommendations, and risk checks in capital markets. The harder challenge begins at execution, where firms need clear accountability, supervision, information controls, and governance architecture before agents can move closer to autonomous decisions.

Read more →

The Wall at the Trading Desk

Agentic AI can already support research, recommendations, and risk checks in capital markets. The harder challenge begins at execution, where firms need clear accountability, supervision, information controls, and governance architecture before agents can move closer to autonomous decisions.

Read more →